Interpace Effecting a 1-for-10 Reverse Stock Split

Dec 28, 2016

|

NEW YORK (GenomeWeb) – Interpace will effect a 1-for-10 reverse stock split in a bid to keep its shares listed on the Nasdaq, the company announced after the close of the market on Wednesday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Interpace Effecting a 1-for-10 Reverse Stock Split

To read the full story....

Breaking News

Somalogic Closes $121M Series A Funding

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

In Brief This Week: Quest Diagnostics, Fluidigm, BD, and More

Tempus Gets CE Mark for xT Tumor Sequencing Assay

BTIG Downgrades Fulgent Genetics from Buy to Neutral

What's Popular?

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

BTIG Downgrades Fulgent Genetics from Buy to Neutral

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Quest Diagnostics Enters Lab Services Agreement With Montefiore Nyack, Goshen Hospital

Abviris Developing Blood-Based Serology Test For HPV-Related Cancers

Sponsorships